Skip to main content

Peer Review reports

From: Posaconazole oral suspension for secondary antifungal prophylaxis in allogeneic stem cell transplantation recipients: a retrospective study

Original Submission
10 Feb 2022 Submitted Original manuscript
5 Mar 2022 Reviewed Reviewer Report
7 Mar 2022 Reviewed Reviewer Report - Julian Lindsay
19 Mar 2022 Author responded Author comments - Ying Lu
22 Mar 2022 Author responded Author comments - Ying Lu
Resubmission - Version 2
19 Mar 2022 Submitted Manuscript version 2
28 Mar 2022 Reviewed Reviewer Report - Julian Lindsay
5 Apr 2022 Reviewed Reviewer Report
14 Apr 2022 Author responded Author comments - Ying Lu
Resubmission - Version 3
14 Apr 2022 Submitted Manuscript version 3
15 Apr 2022 Author responded Author comments - Ying Lu
Resubmission - Version 4
15 Apr 2022 Submitted Manuscript version 4
21 Apr 2022 Reviewed Reviewer Report - Julian Lindsay
21 Apr 2022 Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
29 Apr 2022 Editorially accepted
15 May 2022 Article published 10.1186/s12879-022-07442-y

You can find further information about peer review here.

Back to article page